TESARO IPO watch: Biotechnology company TESARO, Inc. announced its IPO price range of $12-$15 and 6 million shares of common stock will be issued in the public offering. The company intends to raise as much as $81 million. Calculated by an assumed TESARO IPO price of $13.5, the median of the previously announced IPO price range, the company’s market value will reach $377 million.
Tesaro was founded in 2010, and is a biotechnology company focusing on the treatment of chemotherapy-induced symptoms. The company plans to list its common shares on the Nasdaq Stock Exchange under the symbol “TSRO.” Morgan Stanley and LeerinkSwann are acting as the lead underwriters for the for the TESARO IPO.
Find the upcoming IPOs, please go to IPO calendars.